Catalent Acquires Clinical Packaging Facility in Japan to Enhance Clinical Supply Solutions for Asia-Pacific and Global Clients

Somerset, USAMay 21, 2020 /PRNewswire/ --Catalent, Inc. (NYSE: CTLT),Announced today the acquisition of Teva and Takeda Pharmaceutical's located inMinakuchi Town, Koka City, Shiga Prefecture, Japanclinical packaging facilities (Teva and Takeda Pharmaceutical are headquartered in Nagoya, Aichi Prefecture, Japan), this acquisition aims to establish a new GMP-compliant clinical manufacturing and logistics center to support clinical studies. The transaction is expected to be completed on July 1, 2020, and the financial details of the deal have not yet been disclosed.

The clinical facility covers an area of approximately 60,000 square feet., set to become Catalent’s largest clinical supply hub in the Asia-Pacific region, with capabilities in primary and secondary packaging, ambient and cold-chain storage and distribution, as well as clinical returns and destruction. In the future, it will provide customers with Catalent FastChain® demand-driven supply services. It will collaborate with Catalent’s clinical supply facility in Kakegawa, Japan, to deliver comprehensive services to local clients and global biotechnology and pharmaceutical companies.

Ricci Whitlow, President of Catalent’s Clinical Supply business, commented, “We are continuously seeking to expand our capacity in the Asia-Pacific region. This facility meets our needs and builds upon our recent expansion and investment in clinical supply operations in China and Singapore.” “With the growing demand for local clinical services,We will continue to build our strategy for professionalism and production capacity in the region., providing global project support to customers and meeting the growing demands in biologics, cell, and gene therapy research.”

Catalent has established clinical supply centers in the United States, the United Kingdom, Germany, Singapore, Japan, and China, with more than 50 warehousing facilities deployed globally. Its comprehensive clinical supply services are well-equipped to meet international regulatory requirements and extensive distribution needs, supporting both regional and global clinical trials.

For more information on Catalent’s clinical supply services, please visithttps://www.clinical.catalent.com